Baidu
map

血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2021 ICSH建议：用于凝血试验的血样处理

2021-09-27 国际血液学标准委员会 Int J Lab Hematol.2021 Sep 27.

凝血试验

2021年9月，国际血液学标准委员会(ICSH)发布了用于凝血试验的血样处理建议，主要目的是为全世界范围内临床实验室凝血试验用柠檬酸盐血液样本的处理提供指导建议。

中文标题：

2021 ICSH建议：用于凝血试验的血样处理

英文标题：

International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing

发布机构：

国际血液学标准委员会

发布日期：

2021-09-27

简要介绍：

2021年9月，国际血液学标准委员会(ICSH)发布了用于凝血试验的血样处理建议，主要目的是为全世界范围内临床实验室凝血试验用柠檬酸盐血液样本的处理提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ICSH建议：用于凝血试验的血样处理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=748de1c002198334, title=2021 ICSH建议：用于凝血试验的血样处理, enTitle=International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing, guiderFrom=Int J Lab Hematol.2021 Sep 27., authorId=0, author=, summary=2021年9月，国际血液学标准委员会(ICSH)发布了用于凝血试验的血样处理建议，主要目的是为全世界范围内临床实验室凝血试验用柠檬酸盐血液样本的处理提供指导建议。, cover=https://img.medsci.cn/2021929/1632928217181_2020535.jpg, journalId=0, articlesId=null, associationId=1130, associationName=国际血液学标准委员会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Sep 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年9月，国际血液学标准委员会(ICSH)发布了用于凝血试验的血样处理建议，主要目的是为全世界范围内临床实验室凝血试验用柠檬酸盐血液样本的处理提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=23937, tagName=凝血试验)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=69, categoryName=检验与病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=23937, guiderKeyword=凝血试验, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=19192, appHits=79, showAppHits=0, pcHits=1489, showPcHits=19113, likes=0, shares=5, comments=6, approvalStatus=1, publishedTime=Wed Sep 29 23:10:42 CST 2021, publishedTimeString=2021-09-27, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 29 23:10:30 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 17:31:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ICSH建议：用于凝血试验的血样处理.pdf)])
2021 ICSH建议：用于凝血试验的血样处理.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1085710, encodeId=11731085e10e4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/c64ccdf62ceb41c98d8956f2aad14563/b28daf50d44846e39a8edfed883d7d4d.jpg, createdBy=36ed2245282, createdName=苏毓, createdTime=Thu Dec 30 08:57:11 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061882, encodeId=23ce106188251, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:44 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056755, encodeId=e15a1056e556e, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:58 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056511, encodeId=3b5d1056511bc, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c2f5597532, createdName=ms1000001109179906, createdTime=Thu Sep 30 16:07:30 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056446, encodeId=e29f105644695, content=⭐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56175622867, createdName=ms9000001847974753, createdTime=Thu Sep 30 11:57:04 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-12-30 苏毓

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1085710, encodeId=11731085e10e4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/c64ccdf62ceb41c98d8956f2aad14563/b28daf50d44846e39a8edfed883d7d4d.jpg, createdBy=36ed2245282, createdName=苏毓, createdTime=Thu Dec 30 08:57:11 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061882, encodeId=23ce106188251, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:44 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056755, encodeId=e15a1056e556e, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:58 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056511, encodeId=3b5d1056511bc, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c2f5597532, createdName=ms1000001109179906, createdTime=Thu Sep 30 16:07:30 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056446, encodeId=e29f105644695, content=⭐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56175622867, createdName=ms9000001847974753, createdTime=Thu Sep 30 11:57:04 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-10-19 湘雅科教

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1085710, encodeId=11731085e10e4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/c64ccdf62ceb41c98d8956f2aad14563/b28daf50d44846e39a8edfed883d7d4d.jpg, createdBy=36ed2245282, createdName=苏毓, createdTime=Thu Dec 30 08:57:11 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061882, encodeId=23ce106188251, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:44 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056755, encodeId=e15a1056e556e, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:58 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056511, encodeId=3b5d1056511bc, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c2f5597532, createdName=ms1000001109179906, createdTime=Thu Sep 30 16:07:30 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056446, encodeId=e29f105644695, content=⭐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56175622867, createdName=ms9000001847974753, createdTime=Thu Sep 30 11:57:04 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-10-01 13f0c37dm61暂无昵称

    谢谢分享。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1085710, encodeId=11731085e10e4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/c64ccdf62ceb41c98d8956f2aad14563/b28daf50d44846e39a8edfed883d7d4d.jpg, createdBy=36ed2245282, createdName=苏毓, createdTime=Thu Dec 30 08:57:11 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061882, encodeId=23ce106188251, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:44 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056755, encodeId=e15a1056e556e, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:58 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056511, encodeId=3b5d1056511bc, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c2f5597532, createdName=ms1000001109179906, createdTime=Thu Sep 30 16:07:30 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056446, encodeId=e29f105644695, content=⭐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56175622867, createdName=ms9000001847974753, createdTime=Thu Sep 30 11:57:04 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-09-30 ms1000001109179906

    赞

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1085710, encodeId=11731085e10e4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/c64ccdf62ceb41c98d8956f2aad14563/b28daf50d44846e39a8edfed883d7d4d.jpg, createdBy=36ed2245282, createdName=苏毓, createdTime=Thu Dec 30 08:57:11 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061882, encodeId=23ce106188251, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:38:44 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056755, encodeId=e15a1056e556e, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:09:58 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056511, encodeId=3b5d1056511bc, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c2f5597532, createdName=ms1000001109179906, createdTime=Thu Sep 30 16:07:30 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056446, encodeId=e29f105644695, content=⭐, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56175622867, createdName=ms9000001847974753, createdTime=Thu Sep 30 11:57:04 CST 2021, time=2021-09-30, status=1, ipAttribution=)]
    2021-09-30 ms9000001847974753

    ⭐

    0

Baidu
map
Baidu
map
Baidu
map